ALPS Medical Breakthroughs ETF
SBIO
#2393
ETF rank
ยฃ0.10 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ40.22
Share price
-0.33%
Change (1 day)
87.49%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of April 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of April 2026: 0.5%